glp 1 for crohn's GLP-1 Disease: Current Evidence and Treatment Options GLP-1 for Crohn's and colitis

Combatting plateau Access to data beyond weight and BMI is key to promoting a more holistic approach to sustainable weight loss

Arrange Transportation & Post-Op Assistance: Since anesthesia and pain medication can leave you drowsy, you cannot drive yourself home after surgery

Food freshness, intestinal health and DAO support may be more relevant

Good food choices consistently lead to smoother digestion, fewer side effects and lasting progress toward your goals

For obesity treatment in the UK, NHS-commissioned semaglutide 2.4mg (Wegovy) is limited to a maximum of 2 years through specialist weight management services, with specific BMI thresholds (including lower thresholds for some ethnic groups)